Blockade of PD1 and TIM3 restores innate and adaptive immunity in patients with acute alcoholic hepatitis.
about
New treatment options for alcoholic hepatitisMacrophages and Alcohol-Related Liver InflammationAnalysis of peripheral blood dendritic cells as a non-invasive tool in the follow-up of patients with chronic hepatitis CManaging alcoholic liver diseaseInflammatory status in human hepatic cirrhosisUpdate on Alcoholic HepatitisAlcoholic Liver Disease: Role of CytokinesEmerging concepts in alcoholic hepatitisPeg-Interferon Lambda Treatment Induces Robust Innate and Adaptive Immunity in Chronic Hepatitis B Patients.Combination therapy: New hope for alcoholic hepatitis?Animal Models of Alcoholic Liver Disease: Pathogenesis and Clinical RelevanceGalectin-9: Diverse roles in hepatic immune homeostasis and inflammation.Alterations in Activation, Cytotoxic Capacity and Trafficking Profile of Peripheral CD8 T Cells in Young Adult Binge Drinkers.Alcoholic hepatitis: Can we outwit the Grim Reaper?Immune dysfunction in acute alcoholic hepatitis.Maresin 1, a Proresolving Lipid Mediator, Mitigates Carbon Tetrachloride-Induced Liver Injury in MiceInflammation in Alcoholic and Nonalcoholic Fatty Liver Disease: Friend or Foe?Genetic polymorphisms of immune checkpoint proteins PD-1 and TIM-3 are associated with survival of patients with hepatitis B virus-related hepatocellular carcinoma.LPS-TLR4 Pathway Mediates Ductular Cell Expansion in Alcoholic HepatitisCirculating T lymphocyte subsets, cytokines, and immune checkpoint inhibitors in patients with bipolar II or major depression: a preliminary study.Infections in severe alcoholic hepatitis.Targeting of interleukin (IL)-17A inhibits PDL1 expression in tumor cells and induces anticancer immunity in an estrogen receptor-negative murine model of breast cancerInfection does not increase long-term mortality in patients with acute severe alcoholic hepatitis treated with corticosteroids.Sepsis-induced immune alterations monitoring by flow cytometry as a promising tool for individualized therapy.Immunology in the liver--from homeostasis to disease.Alcoholic hepatitis: Translational approaches to develop targeted therapies.Treatment of Severe Alcoholic Hepatitis.Gastric adenocarcinoma.Dysfunctional neutrophil effector organelle mobilization and microbicidal protein release in alcohol-related cirrhosis.Defective monocyte oxidative burst predicts infection in alcoholic hepatitis and is associated with reduced expression of NADPH oxidase.Pathogenesis of Alcoholic Liver Disease.Mucosa-associated invariant T cells link intestinal immunity with antibacterial immune defects in alcoholic liver disease.Acute-on-chronic liver failure in chronic hepatitis B: an update.Immune checkpoint inhibition: prospects for prevention and therapy of hepatocellular carcinoma.Longitudinal assessment of T cell inhibitory receptors in liver transplant recipients and their association with posttransplant infections.Immune checkpoint receptors: homeostatic regulators of immunity.Characterizing the Role of Monocytes in T Cell Cancer Immunotherapy Using a 3D Microfluidic Model.Myeloperoxidase as an Active Disease Biomarker: Recent Biochemical and Pathological Perspectives.
P2860
Q26751402-4EABDB65-E3E7-4E19-A0F9-7DA4AB5A51CBQ26771553-D894A095-27C8-494C-8FFC-C2CC16BF6335Q26773283-1438FA0C-9DC2-430D-85FD-AB4505B6772FQ26777480-1FE6E115-5237-4BF4-A88C-CDAD57795942Q26778040-46DA2600-7A56-47F6-A6AC-C99284BDB33DQ26779121-BC4E9817-2221-4C3A-9B5C-6A56DCA48134Q26783558-C14E8F73-1A59-4EC9-A884-1F09CA53AE6BQ30234425-8775B9F8-A8CE-404A-BAA6-F675C8576013Q33734554-28F639ED-EE74-42C8-B43A-AE6297EAA734Q33746519-8F0FFC2B-DAB2-4180-882D-CE5D4D4DD304Q33882332-81C0BF87-0F45-41B0-B636-E032F786CD4FQ33923368-C548C97A-86D3-4B52-BC75-17F14A62DA88Q35685269-30041D6C-7B13-4974-A36D-4290B0D5A3C5Q35995574-20C84EC4-278B-4BDA-80D5-85DFABFA5D2DQ36269642-854504B9-4B49-44E5-8F72-E985821EFA1CQ36531629-E8490807-E593-42E8-942B-99277135E2E4Q36952109-3913A079-7274-4F4A-AC50-D42209660731Q37295612-4A5150B4-4028-4C18-9A72-9F900301F1F1Q37345576-CD382CB5-EF0F-45D2-8042-9D7BFB658452Q37578777-A3A71AD0-4E16-4AA0-8D4D-7E619A31C482Q37657099-BB61768D-244F-4793-8D22-6BF81D0E5A40Q37702580-BFBBAEAD-E0C4-4BBD-B92A-1FDB287ED127Q37714368-B43065C9-C9D8-4ED3-AAA1-418CDB39880FQ38541110-350EE318-BC0D-4706-998C-625F940878E9Q38693925-E4FF7975-A386-4FD7-BAC5-32FA9BEBE8BCQ38759707-89A4B9B8-9643-40D6-976B-84B54AD242E4Q38763223-8FB0059D-CED6-4B90-8DFD-1F66AB74C592Q39343374-B4BBB8FF-F6EA-4BFD-91D4-A64BA7BAAD3EQ40161364-667C0489-3712-4F33-A93A-E978222C2C86Q40798354-D1A41011-E1A4-46EC-A115-733227DDBADAQ41983037-F1E3AAED-C8C4-4C17-8630-B1D89330626DQ45071749-F7AC9D10-E218-4298-9152-2CBF7C4BCD8EQ47553542-33234116-595B-4B09-A9A8-82A6C9297310Q47554770-090EB317-0C5A-45A4-B931-0F532BF5F347Q50080304-774FEDD2-DD94-483D-A0BF-EDF1B495F3DCQ53685582-9B45CE56-3F7F-4207-A5E4-263B700EF1D8Q54252192-7452C9F8-57DF-4C57-9F2A-74D5ABBC978AQ55426892-52297C08-D8E8-416D-9369-D742EF347E15
P2860
Blockade of PD1 and TIM3 restores innate and adaptive immunity in patients with acute alcoholic hepatitis.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Blockade of PD1 and TIM3 resto ...... ith acute alcoholic hepatitis.
@en
type
label
Blockade of PD1 and TIM3 resto ...... ith acute alcoholic hepatitis.
@en
prefLabel
Blockade of PD1 and TIM3 resto ...... ith acute alcoholic hepatitis.
@en
P2093
P50
P1433
P1476
Blockade of PD1 and TIM3 resto ...... with acute alcoholic hepatitis
@en
P2093
Alex Evans
Elena Palma
Gavin Wright
Godhev K Manakkat Vijay
Helen Cooksley
Jennifer M Ryan
John O'Grady
Lee J L Markwick
Nikhil Vergis
Roger Williams
P304
590-602.e10
P356
10.1053/J.GASTRO.2014.11.041
P407
P577
2014-12-02T00:00:00Z